Kyn Therapeutics Banks $49M to Advance Cancer Immunometabolism Therapies Post author:Sam Post published:December 13, 2017 Post category:BioPharma Investors were Atlas Venture and OrbiMed. Source: BioSpace You Might Also Like Cancer Biotech Novocure Scores New $150M Debt Financing February 7, 2018 <b>Phosphorus</b> Announces Formation Of Scientific Advisory Board February 28, 2017 GlaxoSmithKline's ViiV Healthcare Wins First FDA OK for Two-Drug HIV Regimen November 21, 2017
